| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0049-3848(03)00146-4 |
| P698 | PubMed publication ID | 12757777 |
| P2093 | author name string | Mikael Tranholm | |
| Rasmus Rojkjaer | |||
| Morris A Blajchman | |||
| Annemarie T Kristensen | |||
| Charles Pyke | |||
| Birgitte Klitgaard | |||
| Karsten Lollike | |||
| P2860 | cites work | Effects of agents, used to treat bleeding disorders, on bleeding time prolonged by a very high dose of a direct thrombin inhibitor in anesthesized rats and rabbits | Q32067238 |
| Effect of recombinant factor VIIa (Novoseven) on thrombocytopenia-like conditions in vitro | Q33340108 | ||
| Effective hemostasis with rFVIIa treatment in two patients with severe thrombocytopenia and life-threatening hemorrhage | Q33341446 | ||
| The thrombocytopenic rabbit bleeding time model to evaluate the in vivo hemostatic efficacy of platelets and platelet substitutes | Q33499204 | ||
| Crossmatch-compatible platelets improve corrected count increments in patients who are refractory to randomly selected platelets | Q33499542 | ||
| Recombinant factor VIIa for patients with inhibitors to factor VIII or IX or factor VII deficiency | Q40633560 | ||
| Approaches towards successful home treatment in patients with inhibitors. | Q45855522 | ||
| A randomized, double-blind comparison of two dosage levels of recombinant factor VIIa in the treatment of joint, muscle and mucocutaneous haemorrhages in persons with haemophilia A and B, with and without inhibitors. rFVIIa Study Group | Q45856561 | ||
| Blocking of tissue factor pathway inhibitor (TFPI) shortens the bleeding time in rabbits with antibody induced haemophilia A. | Q45876184 | ||
| Mechanism of factor VIIa-dependent coagulation in hemophilia blood | Q45882859 | ||
| Platelet activity of high-dose factor VIIa is independent of tissue factor | Q45884609 | ||
| Platelet-dependent action of high-dose factor VIIa | Q45887481 | ||
| Effects of recombinant activated factor VII on coagulation measured by thromboelastography in liver transplantation | Q62107359 | ||
| Effect of recombinant activated factor VII on perioperative blood loss in patients undergoing retropubic prostatectomy: a double-blind placebo-controlled randomised trial | Q78840677 | ||
| P433 | issue | 4 | |
| P921 | main subject | thrombocytopenia | Q585285 |
| P304 | page(s) | 217-223 | |
| P577 | publication date | 2003-02-01 | |
| P1433 | published in | Thrombosis Research | Q15758741 |
| P1476 | title | Recombinant factor VIIa reduces bleeding in severely thrombocytopenic rabbits | |
| P478 | volume | 109 |
| Q33369021 | Control of bleeding caused by thrombocytopenia associated with hematologic malignancy: an audit of the clinical use of recombinant activated factor VII. |
| Q36284643 | Preclinical trauma studies of recombinant factor VIIa |
| Q47243999 | Recombinant human factor VIIa and a factor VIIa-analogue reduces heparin and low molecular weight heparin (LMWH)-induced bleeding in rats |
| Q33427920 | The Effects of Exogenous Administration of Human Coagulation Factors Following Pig-to-Baboon Liver Xenotransplantation |
Search more.